An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells
Clinical trial NCT01753453 · COMPLETED
Trial details
- NCT number
- NCT01753453
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-09-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.